MedTrace Logo

Colorectal Cancer Screening in Cystic Fibrosis

NCT05362344 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2026-03-24

No results posted yet for this study

Summary

This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).

Conditions

Interventions

PROCEDURE

Stool tests

Non-invasive, stool-based tests for colorectal cancer screening.

Sponsors & Collaborators

  • Cystic Fibrosis Foundation

    collaborator OTHER

  • University of Washington, the Collaborative Health Studies Coordinating Center

    lead OTHER

Principal Investigators

  • Christine Hachem, MD · St. Louis University

  • Sarah Jane Schwarzenberg, MD · University of Minnesota

  • Steven D. Freedman, MD, PhD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2025-03-21
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05362344 on ClinicalTrials.gov